TY - JOUR
T1 - Remodeling of tissue-engineered bone structures in vivo
AU - Hofmann, Sandra
AU - Hilbe, Monika
AU - Fajardo, Robert J.
AU - Hagenmüller, Henri
AU - Nuss, Katja
AU - Arras, Margarete
AU - Müller, Ralph
AU - Von Rechenberg, Brigitte
AU - Kaplan, David L.
AU - Merkle, Hans P.
AU - Meinel, Lorenz
N1 - Funding Information:
We thank Sandra Hanses for her assistance with surgery, and Flora Nicholls for managing anesthesia, postoperative care, and monitoring of the animals. Financial support by the Alexander von Humboldt Foundation (Bonn, Germany) , NIH ( P41 EB002520 ) the NCCR CO-ME of the Swiss National Science Foundation, and ETH Zurich (TH-Gesuch) is gratefully acknowledged.
PY - 2013/9
Y1 - 2013/9
N2 - Implant design for bone regeneration is expected to be optimized when implant structures resemble the anatomical situation of the defect site. We tested the validity of this hypothesis by exploring the feasibility of generating different in vitro engineered bone-like structures originating from porous silk fibroin scaffolds decorated with RGD sequences (SF-RGD), seeded with human mesenchymal stem cells (hMSC). Scaffolds with small (106-212 μm), medium (212-300 μm), and large pore diameter ranges (300-425 μm) were seeded with hMSC and subsequently differentiated in vitro into bone-like tissue resembling initial scaffold geometries and featuring bone-like structures. Eight weeks after implantation into calvarial defects in mice, the in vitro engineered bone-like tissues had remodeled into bone featuring different proportions of woven/lamellar bone bridging the defects. Regardless of pore diameter, all implants integrated well, vascularization was advanced, and bone marrow ingrowth had started. Ultimately, in this defect model, the geometry of the in vitro generated tissue-engineered bone structure, trabecular- or plate-like, had no significant impact on the healing of the defect, owing to an efficient remodeling of its structure after implantation.
AB - Implant design for bone regeneration is expected to be optimized when implant structures resemble the anatomical situation of the defect site. We tested the validity of this hypothesis by exploring the feasibility of generating different in vitro engineered bone-like structures originating from porous silk fibroin scaffolds decorated with RGD sequences (SF-RGD), seeded with human mesenchymal stem cells (hMSC). Scaffolds with small (106-212 μm), medium (212-300 μm), and large pore diameter ranges (300-425 μm) were seeded with hMSC and subsequently differentiated in vitro into bone-like tissue resembling initial scaffold geometries and featuring bone-like structures. Eight weeks after implantation into calvarial defects in mice, the in vitro engineered bone-like tissues had remodeled into bone featuring different proportions of woven/lamellar bone bridging the defects. Regardless of pore diameter, all implants integrated well, vascularization was advanced, and bone marrow ingrowth had started. Ultimately, in this defect model, the geometry of the in vitro generated tissue-engineered bone structure, trabecular- or plate-like, had no significant impact on the healing of the defect, owing to an efficient remodeling of its structure after implantation.
KW - Bone
KW - In vivo
KW - Remodeling
KW - Silk fibroin
KW - Stem cell
KW - Tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=84882939607&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882939607&partnerID=8YFLogxK
U2 - 10.1016/j.ejpb.2013.02.011
DO - 10.1016/j.ejpb.2013.02.011
M3 - Article
C2 - 23958323
AN - SCOPUS:84882939607
SN - 0939-6411
VL - 85
SP - 119
EP - 129
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
IS - 1
ER -